Bellerophon Therapeutics, Inc. (BLPH): Price and Financial Metrics
BLPH Price/Volume Stats
| Current price | $0.01 | 52-week high | $0.02 |
| Prev. close | $0.02 | 52-week low | $0.01 |
| Day low | $0.01 | Volume | 7,000 |
| Day high | $0.01 | Avg. volume | 18,900 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 146.80K |
BLPH Stock Price Chart Interactive Chart >
Bellerophon Therapeutics, Inc. (BLPH) Company Bio
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates are INOpulse, a pulsatile nitric oxide delivery device, which is in Phase III clinical trials for the treatment of pulmonary arterial hypertension; and in Phase II clinical trials to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases and pulmonary hypertension associated with idiopathic pulmonary fibrosis. Bellerophon Therapeutics, Inc. was founded in 2009 and is founded in Warren, New Jersey.
BLPH Price Returns
| 1-mo | -81.82% |
| 3-mo | -71.43% |
| 6-mo | -82.14% |
| 1-year | -71.43% |
| 3-year | -99.65% |
| 5-year | -99.80% |
| YTD | -72.97% |
| 2023 | -95.89% |
| 2022 | -70.97% |
| 2021 | -53.52% |
| 2020 | 27.16% |
| 2019 | -56.29% |
Loading social stream, please wait...